Morepen Laboratories Limited is a pharmaceutical company. The Company is in the business of manufacturing, producing, developing and marketing a range of active pharmaceutical ingredients (APIs), branded and generic formulations and also home health products. Its APIs include Apixaban, Edoxaban, Linagliptin, Linagliptin + Metformin, Empagliflozin, Empagliflozin + Metformin, Atorvastatin, Rosuvastain, Rivaroxaban, Febuxostat, Montelukast (Oral), Montelukast (Chewable), Montelukast Sodium, among others. Its finished formulations include Intebact Capsules, Intelicaps Lax, Rythmix Kid Drop, Rythmix Kid Syrup, Kompact Powder, Saltum and Acifix 3X Suspension among others. Its home health products include Dr. Morepen 49W Room Air Purifier with HEPA Filter, Dr. Morepen VP06 Breathe Free Vaporizer, Dr. Morepen CN06 Compressor Nebulizer and Dr. Morepen ST03 Dual Head Stethoscope, among others. Its subsidiaries include Dr. Morepen Limited, Morepen Devices Limited, and Total Care Limited.
Morepen Laboratories Ltd FAQs
How to Buy Morepen Laboratories Ltd Share?
To purchase Morepen Laboratories Ltd shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Morepen Laboratories Ltd (ticker symbol: MOREPENLAB) on the trading platform provided by your broker and purchase the shares.
The stock price of Morepen Laboratories Ltd as of 07 Oct 2025 is ₹47.86
What is the Market Cap of Morepen Laboratories Ltd?
Market capitalisation represents the total market value of a company's outstanding shares. As of 07 Oct 2025, Morepen Laboratories Ltd (ticker symbol: MOREPENLAB) has a market capitalisation of approximately ₹27,00,00,00,000.00
What is the PE and PB ratio of Morepen Laboratories Ltd?
Morepen Laboratories Ltd Ltd's price-to-book ratio as of 07 Oct 2025 is 2.27, reflecting the market's valuation compared to its asset value. As of 07 Oct 2025, the trailing twelve months P/E (price-to-earnings) ratio is 22.26, indicating the market values the company at around ₹22.26 for every ₹1 of earnings
What is the 52 Week High and Low of Morepen Laboratories Ltd Share?
Morepen Laboratories Ltd Ltd (MOREPENLAB) hit its 52-week high at ₹94.45, and its 52-week low at ₹42.00.